Opinions

Alaskans need affordable prescriptions

Here’s a simple fact: Many Alaskans are struggling to pay for their prescription drugs. This can mean going without their needed medicines, cutting pills in half, and even having to make the excruciating choice between paying rent or utility bills, buying food and paying for life-saving prescriptions, whose prices continue to skyrocket.

It’s no wonder that older adults worry about the cost of prescription drugs. AARP has tracked price trends for nearly two decades, and our research consistently finds that the prices for brand name medications most often used by seniors are increasing much faster than prices for other goods and services.

Congress is currently considering a bold proposal that would dramatically reduce drug price increases, by simply allowing Medicare to negotiate the prices it pays for prescription drugs.

Let’s be clear: This is not a partisan issue. An AARP survey shows that 87% of registered voters 50 plus support allowing Medicare to negotiate with drug companies. Right now, the program is largely stuck paying whatever price pharmaceutical companies demand — leaving the government on the hook for sky-high costs that increase every year.

The good news is that bills currently before Congress would save both seniors and taxpayers billions of dollars on prescription drugs — and ensure that Americans are paying fair prices for the medications we need. It’s outrageous that we have to pay three times what people in other countries pay for the same medicine.

Every year, Medicare spends more than $129 billion on prescription drugs. Yet it’s prohibited by law from using its buying power to negotiate with drug companies to get lower prices. Giving Medicare the power to negotiate will save taxpayers and people on Medicare $117 billion and lower prescription drug costs for all Americans.

Consider this: In just under a decade, almost 70% of drug companies increased their annual profit margins while patients faced double-digit price increases. AARP’s most recent Rx Price Watch Report found that the prices of 260 widely used brand-name medications rose more than twice as fast as general inflation in 2020 — in the middle of a global pandemic and financial downturn. Americans now spend more than $360 billion per year on prescription drugs.

The federal government continues to play an outsized role in prescription drug research and development. In fact, most of the important new drugs introduced over the past 60 years were developed with the aid of research conducted in the public sector. By allowing the program to use its considerable buying power to negotiate, both seniors and taxpayers could see significantly lower costs.

We, the consumers, pay for the high prices for prescription drugs, regardless of whether we’re taking them ourselves. In addition to co-pays at the pharmacy counter, we pay for medication costs through our insurance premiums and taxes that fund government programs like the Veterans Administration (VA), Medicare, and Medicaid.

It’s simply not right that Americans are stuck paying the highest prices in the world for our prescription drugs, and we simply can’t wait any longer for affordable prescription drugs.

Madeline G. Holdorf, M.Ed., is the volunteer State President for AARP Alaska. She continues her lifelong community activism pursuits with volunteer commitments to organizations including AARP, the Anchorage Senior Activity Center, SAGE Alaska, the Village to Village Network and St. Mark Lutheran Church. She has been an AARP member since 1996.

The views expressed here are the writer’s and are not necessarily endorsed by the Anchorage Daily News, which welcomes a broad range of viewpoints. To submit a piece for consideration, email commentary(at)adn.com. Send submissions shorter than 200 words to letters@adn.com or click here to submit via any web browser. Read our full guidelines for letters and commentaries here.